moxalactam has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caparosa, R; Haverkos, HW; Kamerer, D; Yu, VL | 1 |
| Brouwers, J; Davies, BI; Debruyne, H; Maesen, FP; Nelissen-Wamper, M; Salemans, T | 1 |
2 other study(ies) available for moxalactam and Chronic Disease
| Article | Year |
|---|---|
Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis.
Topics: Aged; Cephalosporins; Cephamycins; Chronic Disease; Diabetes Complications; Female; Humans; Male; Mastoiditis; Middle Aged; Moxalactam; Otitis Externa; Otitis Media; Otitis Media, Suppurative; Pseudomonas Infections | 1982 |
Latamoxef (moxalactam) in acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cephalosporins; Cephamycins; Chronic Disease; Humans; Kinetics; Microbial Sensitivity Tests; Moxalactam; Sputum; Time Factors | 1983 |